slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 46,321-46,350
Pages 10,126
Rows per page 30
Component
46,321-46,350 of 303,780
01
AstraZeneca | Results Presentation Deck | 157 slidesAstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem2 hits
19
The slide is part of an appendix section detailing clinical trial status for specific drug assets.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction2 hits
25
The slide uses a standard clinical trial registry format for reporting pipeline progress.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution2 hits
35
The slide is part of an appendix section, indicated by the page number and glossary link.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle2 hits
36
The slide is part of an appendix, detailing specific trial designs, patient counts, and status for TROPION-PanTumor trials.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle2 hits
40
The table lists five distinct clinical trials (SERENA-2, SERENA-3, NCT04541433, SERENA-1, NCT04818632).AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle2 hits
41
The slide is part of an appendix section detailing clinical trial pipelines.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution2 hits
42
The slide is part of an appendix, specifically detailing late-stage development assets.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution2 hits
43
The slide is part of an appendix, providing detailed clinical trial data for a specific asset.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution2 hits
44
The slide provides a structured overview of four specific clinical trials (EvoPAR-Prostate01, EvoPAR-Breast01, PETRA, PETRANHA).AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution2 hits
45
The slide is part of an appendix, providing specific clinical trial data for a drug candidate.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution2 hits
47
Slide 47 of a presentation deck.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution2 hits
50
Part of a pipeline appendix deck.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution2 hits
52
Part of a larger portfolio deck, indicated by the vertical navigation bar on the right.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution2 hits
54
Slide 54 of a larger deck, part of the appendix.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution2 hits
57
The slide provides a summary of two clinical trials (PRIMROSE and PRIMAVERA) including population, patient counts, design, endpoints, and status.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution2 hits
03
AstraZeneca | Results Presentation Deck | 38 slidesAstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations 2 hits
06
ERoW = Established Rest of World comprises Japan, Canada, Australia, and New Zealand.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations Beat · Need2 hits
09
The chart uses color coding for different product categories, though no legend is provided.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations 2 hits
12
Includes a waterfall chart for net debt and specific guidance updates for revenue and EPS.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations 2 hits
14
The slide uses a stacked bar chart to show revenue trends by product over time, paired with a list of qualitative drivers.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations 2 hits
15
The slide uses a two-column layout to separate solid tumor (bladder cancer) and haematology R&D updates.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations Loop · Voice Of Customer2 hits
16
Slide 16 of a presentation deck. Includes a legend for established SoC vs ongoing trials.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations Loop · Voice Of Customer2 hits
18
Slide 18 of a presentation. Includes revenue charts for CVRM and R&I segments and a list of key product growth drivers.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations Loop · Voice Of Customer2 hits
19
The slide uses a matrix-like structure to map drug candidates against therapeutic areas and treatment strategies.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations Loop · Voice Of Customer2 hits
20
The slide uses a split-layout: left side details the clinical trial results, right side lists pipeline expansion opportunities.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations Loop · Voice Of Customer2 hits
22
Includes revenue breakdown by product (Ultomiris, Soliris, Strensiq, Others) over 8 quarters.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations 2 hits
23
The slide uses a split-panel layout to define the problem (NF1-PN) and the solution (KOMET trial results).AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations 2 hits
30
The slide uses a matrix structure to categorize clinical assets by disease stage and biomarker status (IO sensitive, EGFRm, etc.).AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations 2 hits
31
The slide uses a grid layout to categorize clinical trials (e.g., DESTINY-Breast, TROPION-Breast) against patient segments and treatment lines.AstraZeneca | Results Presentation Deck | 38 slides · AstraZeneca
Conference presentation Investor relations 2 hits